Repligen

USA

Repligen

Building 1 Suite 100

Walter C. Herlihy,
President and Chief Executive Officer
Michael L. Hall,
Chief Medical Officer
Senior Vice President, Clinical and Regulatory Affairs
Jonathan I. Lieber,
Chief Financial Officer and Treasurer
William J. Kelly,
Chief Accounting Officer
James R. Rusche,
Senior Vice President, Research and Development
Daniel P. Witt,
Senior Vice President, Global Operations
Howard Benjamin,
Vice President, Business Development
Stephen Tingley,
Vice President, Bioprocessing Sales and Marketing

Терапия

Производство

Метаболический синдром

RGEN

Glenn L. Cooper,
Karen A. Dawes,
Chairman
Alfred L. Goldberg
Michael A. Griffith
Earl Webb Henry
Walter C. Herlihy
Alexander Rich
Thomas F. Ryan Jr.

1.3500

Биоинженерия, Другое, Клеточные технологии, Моноклональные антитела, Сервисы